- Advertisement -

Tau and Alzheimer’s Disease

Read Now<img decoding="async" src="https://www.genengnews.com/wp-content/uploads/2026/08/2607_Nautilus_eBook_Cover-232x300.jpg" alt="Tau andAlzheimer’sDisease eBook cover” class=”wp-image-336117″/>The last few decades have seen rapid advances in Alzheimer’s disease (AD) research. From the development...

Delays and shortages hit SARS-CoV-2 genomic surveillance program

Soon after the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) began to spread over the world, leading to the devastating pandemic of...

Genetic Analysis of Bacterial Strains Causing Lyme Disease Could Transform Treatment

An international team of scientists reports that it has unraveled the genetic makeup of 47 strains of known and potential Lyme disease-causing bacteria. The...

In a First, Solid Humanized Kidneys Grown Inside Pigs

A severe organ shortage plagues the progress of organ transplantation. One solution may be to generate human organs in other large mammals, however, that...

Researchers develop protein-based nanoparticles to neutralize SARS-CoV2 virus

Nanomaterials inspired by amyloid proteins are gaining interest in nanotechnology, due to their modularity, controlled self-assembly and stability. A key advantage of these materials...

New grants support research on mechanics of tumor cells

At the cellular level, cancer can be viewed as a mechanical engineering challenge. The disease alters the structure and function of cells and tissues,...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs

Researchers headed by a team at the Centre for Kidney and Bladder Health, Division of Medicine, University College London, have used a novel human...

more new items

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne...

Switzerland-headquartered NewBiologix signed an agreement with Synastra Biotechnology to develop a stable producer cell line for Synastra’s investigational Duchenne muscular dystrophy (DMD) gene therapy...

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Medicines Discovery Catapult (MDC) invested in two U.K. biotechs developing new  approaches to treating diseases such as psoriasis. Parkinson’s Flip Therapeutics and Nascent Therapeutics...

Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent...

Researchers headed by a team at the Centre for Kidney and Bladder Health, Division of Medicine, University College London, have used a novel human...